Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Melanoma

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 36 articles: HTML format Text format

Single Articles

April 2010
1. LASITHIOTAKIS K , Economou G, Gogas H, Ioannou C, et al
   Hyperthermic isolated limb perfusion for recurrent melanomas and soft tissue sarcomas: Feasibility and reproducibility in a multi-institutional Hellenic collaborative study.
   Oncol Rep. 2010;23:1077-83.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CHEN RY , Chen HX, Jian P, Xu L, et al
   Intratumoral injection of pEGFC1-IGFBP7 inhibits malignant melanoma growth in C57BL/6J mice by inducing apoptosis and down-regulating VEGF expression.
   Oncol Rep. 2010;23:981-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. CHENG Y , Li J, Martinka M, Li G, et al
   The expression of NAD(P)H:quinone oxidoreductase 1 is increased along with NF-kappaB p105/p50 in human cutaneous melanomas.
   Oncol Rep. 2010;23:973-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. ELLERHORST JA , Diwan AH, Dang SM, Uffort DG, et al
   Promotion of melanoma growth by the metabolic hormone leptin.
   Oncol Rep. 2010;23:901-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2010
5. ROUTHIER A , Astuccio M, Lahey D, Monfredo N, et al
   Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth.
   Oncol Rep. 2010;23:861-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
6. SONODA Y , Warita M, Suzuki T, Ozawa H, et al
   Proteolipid protein 2 is associated with melanoma metastasis.
   Oncol Rep. 2010;23:371-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. MURTAS D , Piras F, Minerba L, Ugalde J, et al
   Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.
   Oncol Rep. 2010;23:329-35.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
8. PIRAS F , Perra MT, Murtas D, Minerba L, et al
   The stem cell marker nestin predicts poor prognosis in human melanoma.
   Oncol Rep. 2010;23:17-24.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
9. QUATRESOOZ P , Pierard-Franchimont C, Pierard GE
   Molecular histology on the diagnostic cutting edge between malignant melanomas and cutaneous melanocytomas (Review).
   Oncol Rep. 2009;22:1263-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
10. CHAN RC , Gutierrez B, Ichim TE, Lin F, et al
    Enhancement of DNA cancer vaccine efficacy by combination with anti-angiogenesis in regression of established subcutaneous B16 melanoma.
    Oncol Rep. 2009;22:1197-203.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
11. GE W , Hu PZ, Huang Y, Wang XM, et al
    The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following different administration routes.
    Oncol Rep. 2009;22:915-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
12. SUN Q , Cong R, Yan H, Gu H, et al
    Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression.
    Oncol Rep. 2009;22:563-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
13. AKIYAMA Y , Tai S, Komiyama M, Takikawa M, et al
    Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients.
    Oncol Rep. 2009;22:185-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
14. CHEN L , Zhang S, Li X, Sun B, et al
    A pilot study of vasculogenic mimicry immunohistochemical expression in intraocular melanoma model.
    Oncol Rep. 2009;21:989-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. CHEN L , Sun B, Zhang S, Zhao X, et al
    Influence of microenvironments on microcirculation patterns and tumor invasion-related protein expression in melanoma.
    Oncol Rep. 2009;21:917-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. NAKAMURA T , Matsumine A, Kato H, Kusuzaki K, et al
    Malignant melanoma with a rhabdoid phenotype exhibiting numerous solid tumor masses: A case report.
    Oncol Rep. 2009;21:887-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
17. COSTA MA , Gulino L, Pellerito L, Fiore T, et al
    Effects of two organotin(IV)(sulfonatophenyl)porphinates on MAPKs and on the growth of A375 human melanoma cells.
    Oncol Rep. 2009;21:593-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
18. KIM YI , Shin MK, Lee JW, Chung JH, et al
    Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Oncol Rep. 2009;21:159-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
19. BAR J , Yerushalmi R, Shapira-Frummer R, Kutchuk I, et al
    Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma.
    Oncol Rep. 2008;20:1533-1538.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. REINHOLD U , Schmitz B, Kurbacher C, Nagel W, et al
    Circulating 25-hydroxyvitamin D concentration in German cancer patients.
    Oncol Rep. 2008;20:1539-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
21. ROOMI MW , Kalinovsky T, Roomi NW, Ivanov V, et al
    Suppression of growth and hepatic metastasis of murine B16FO melanoma cells by a novel nutrient mixture.
    Oncol Rep. 2008;20:809-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
22. WU J , Zhang L, Ma X, Zhang X, et al
    Screening cellular proteins involved in the anti-proliferative effect of the ADAM15 disintegrin domain in murine melanoma cells.
    Oncol Rep. 2008;20:669-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. KIM A , Jung JY, Son M, Lee SH, et al
    Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma.
    Oncol Rep. 2008;20:557-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
24. PIRAS F , Perra MT, Murtas D, Minerba L, et al
    Combinations of apoptosis and cell-cycle control biomarkers predict the outcome of human melanoma.
    Oncol Rep. 2008;20:271-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
25. KERTAT K , Rosdahl I, Sun XF, Synnerstad I, et al
    The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: A case control study in the Swedish population.
    Oncol Rep. 2008;20:179-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
26. FANG L , Wang K, Liu X, Zhang L, et al
    A study on anti-tumor immunity induced by gene-modified melanoma B16 cells.
    Oncol Rep. 2008;19:1589-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. HEO JC , Son M, Woo SU, Kweon MA, et al
    A fraction of methylene chloride from Geum japonicum Thunberg inhibits tumor metastatic and angiogenic potential.
    Oncol Rep. 2008;19:1399-403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. OGAWA Y , Ue H, Tsuzuki K, Tadokoro M, et al
    New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms.
    Oncol Rep. 2008;19:1389-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
29. ZHAO Y , Liu J, McMartin KE
    Inhibition of NADPH oxidase activity promotes differentiation of B16 melanoma cells.
    Oncol Rep. 2008;19:1225-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. BASAK GW , Zapala L, Wysocki PJ, Mackiewicz A, et al
    Interleukin 15 augments antitumor activity of cytokine gene-modified melanoma cell vaccines in a murine model.
    Oncol Rep. 2008;19:1173-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. HATA H , Kitamura T, Higashino F, Hida K, et al
    Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
    Oncol Rep. 2008;19:1093-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
32. TENTORI L , Dorio AS, Muzi A, Lacal PM, et al
    The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma.
    Oncol Rep. 2008;19:1039-1043.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. WONG RP , Khosravi S, Martinka M, Li G, et al
    Myeloid leukemia-1 expression in benign and malignant melanocytic lesions.
    Oncol Rep. 2008;19:933-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
34. RIVERA RS , Nagatsuka H, Siar CH, Gunduz M, et al
    Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma.
    Oncol Rep. 2008;19:657-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
35. BUNDSCHERER A , Hafner C, Maisch T, Becker B, et al
    Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines.
    Oncol Rep. 2008;19:547-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
36. DUVAL RE , Harmand PO, Jayat-Vignoles C, Cook-Moreau J, et al
    Differential involvement of mitochondria during ursolic acid-induced apoptotic process in HaCaT and M4Beu cells.
    Oncol Rep. 2008;19:145-9.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: